Search Results1-20 of  265

  • Ken KATO ID: 9000412529831

    Articles in CiNii:1

    • Visions of American social security : Issac M. Rubinow, John R. Commons, and Edwin E. Witte (2015)
  • Kato Ken-ichi ID: 9000009494185

    Articles in CiNii:1

    • Isotope Ratio of Europium in Procyon (1987)
  • Kato Ken ID: 9000264862518

    Articles in CiNii:1

    • Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer : combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912 (2014)
  • Kato Ken ID: 9000266435623

    Articles in CiNii:1

    • A phase Ⅱ study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus : The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI) (2014)
  • Kato Ken ID: 9000322739868

    Articles in CiNii:1

    • A nation-wide survey of follow-up strategies for esophageal cancer patients after a curative esophagectomy or a complete response by definitive chemoradiotherapy in Japan (2016)
  • Kato Ken ID: 9000329420849

    Articles in CiNii:1

    • Neo-adjuvant therapy or definitive chemoradiotherapy can improve laryngeal preservation rates in patients with cervical esophageal cancer. A Japanese nationwide survey (2016)
  • Kato Ken ID: 9000361230013

    Articles in CiNii:1

    • Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes (2017)
  • Kato Ken ID: 9000368922022

    Articles in CiNii:1

    • Decreased risk of esophageal cancer owing to cigarette and alcohol cessation in smokers and drinkers : a systematic review and meta-analysis (2017)
  • Kato Ken ID: 9000368922167

    Articles in CiNii:1

    • Clinicopathological features and pathological evaluation of preoperative treatment of patients with resectable esophageal carcinosarcoma (2017)
  • Kato Ken ID: 9000390405198

    Articles in CiNii:1

    • A phase Ⅱ study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer (2018)
  • Kato Ken ID: 9000399796326

    Articles in CiNii:1

    • Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society(part 1) (2019)
  • Kato Ken ID: 9000399796350

    Articles in CiNii:1

    • Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society(part 2) (2019)
  • Kato Ken ID: 9000401420815

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • Kato Ken ID: 9000403259669

    Articles in CiNii:1

    • Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer (2019)
  • Kato Ken ID: 9000404619783

    Articles in CiNii:1

    • Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer (2019)
  • Kato Ken ID: 9000406185114

    Articles in CiNii:1

    • Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial : a randomized phase Ⅲ clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer (2020)
  • Kato Ken ID: 9000409014723

    Articles in CiNii:1

    • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2) : 2-year update data (2020)
  • Kato Ken ID: 9000410329666

    Articles in CiNii:1

    • The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage Ⅱ/Ⅲ esophageal cancer : an exploratory analysis of JCOG0909 (2020)
  • Kato Ken ID: 9000411378054

    Articles in CiNii:1

    • Influence of preoperative chemotherapy-induced leukopenia on survival in patients with esophageal squamous cell carcinoma : exploratory analysis of JCOG9907 (2021)
  • Kato Ken ID: 9000411378134

    Articles in CiNii:1

    • Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma : a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3) (2021)
Page Top